Abstract

Aim:This study was designed to evaluate the resistin levels in GCF of patients with periodontitis and type 2 diabetes mellitus(T2DM) after non-surgical periodontal therapy and subantimicrobial dosage doxycycline(SDD).Subjects & Methods:Thirty periodontal sites within 24 patients with age ranged between(24-51) years old were selected for this study.Total of 30 periodontal sites were randomly divided into three groups;each group included ten periodontal sites:(group I):systemically healthy periodontitis patients who were received scaling and root planning (SRP),(group II):periodontitis patients with T2DM who were received SRP, and(group III):periodontitis patients with T2DM who were received SRP and SDD 20mg twice/day. All patients were examined with clinical periodontal parameters: plaque index(PI), gingival index(GI), probing depth(PD) and clinical attachment level(CAL).Patients in each groups underwent nonsurgical periodontal therapy combined with a maintenance program (including brushing with regular toothpaste). GCF samples were collected in all patients at baseline, one month as well as 3 months after periodontal therapy. Quantification of resistin in human samples was measured using resistin ELISA test. Results: Non-surgical periodontal therapy resulted in relative improvement in all clinical parameters as well as a decrease in resistin levels.In addition, GCF levels of resistin, PD , GI were greater reduction after non-surgical treatment in group III than group II.Conclusions:Non surgical periodontal therapy is found to be effective in the treatment of periodontitis patients with and without diabetes mellitus and also GCF resistin can be a useful biomarker to detect the periodontal disease condition.Also, adjunctive use of SDD showed more clinical benefit to patients with periodontitis by host response modulation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call